<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Science and Education Publishing</publisher>
<journalTitle>American Journal of Public Health Research</journalTitle>
<eissn>2327-6703</eissn>
<publicationDate>2025-10-17</publicationDate>
<volume>13</volume>
<issue>5</issue>
<startPage>208</startPage>
<endPage>223</endPage>
<doi>10.12691/ajphr-13-5-2</doi>
<publisherRecordId>AJPHR20251352</publisherRecordId>
<documentType>article</documentType>
<title language="eng">Protective Effects of Lady¡¯s Mantle (Alchemilla vulgaris L.) against Hepatotoxicity in a Rat Model: Insights into Active Compounds and Underlying Mechanisms</title>
<authors>
<author>
<name>Yousif A. Elhassaneen</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Amira H. Darwish</name>
<affiliationId>1</affiliationId>
</author>
<author>
<name>Alaa A. Mosa</name>
<affiliationId>1</affiliationId>
</author>

</authors>
<affiliationsList>
<affiliationName affiliationId="1">Department of Nutrition and Food Science, Faculty of Home Economics, Menoufia University, Shebin El-Kom, Egypt</affiliationName>


</affiliationsList>
<abstract language="eng">Alchemilla vulgaris (Lady¡¯s mantle) has shown various therapeutic properties, yet its liver-protective potential remains underexplored. This study aimed to evaluate its hepatoprotective effects in a rat model of CCl?-induced liver toxicity and to characterize its bioactive compounds. Thirty rats were divided into five groups: a negative control, a CCl?-induced positive control, and three treatment groups receiving ethanol extract of Lady¡¯s mantle (AVE) at doses of 150, 300, and 450 mg/kg body weight/day. Proximate analysis of the aerial parts revealed 39.86% carbohydrates, 30.92% crude fiber, 15.94% protein, 10.83% ash, and 2.45% fat. The ethanol extract was rich in bioactive compounds, including phenolics (621.67 &#181;g GAE/g), terpenoids (411.52 &#181;g/g), anthocyanins (214.66 &#181;g/g), flavonoids (181.45 &#181;g/g), and triterpenoids (129.34 &#181;g/g). AVE exhibited strong antioxidant activity (87.34%), with an IC50 of 14.42 &#181;g/mL. In the biological study, AVE treatment dose-dependently improved body weight gain, food intake, and feed efficiency ratio in hepatotoxic rats. Liver function markers also improved, with glycogen content increasing by 128.64%, G6PD activity by 95.78%, and G6Pase activity decreasing by 53.25% at the highest dose. Serum lipid profiles were corrected, with HDL-c increasing by up to 65.06%, LDL-c decreasing by 32.52%, and total cholesterol dropping by up to 9.42%. Antioxidant defenses were restored as reduced glutathione increased by 89.49%, while oxidative stress markers such as ROS and MDA decreased by up to 53.61% and 26.01%, respectively. Histopathological analysis confirmed reduced liver damage and inflammation in treated groups. In conclusion, Alchemilla vulgaris ethanol extract demonstrates potent antioxidant and hepatoprotective properties. Further investigation may support its use as a natural therapeutic agent for liver disorders.</abstract>
<fullTextUrl format="pdf">https://pubs.sciepub.com/ajphr/13/5/2/ajphr-13-5-2.pdf</fullTextUrl>
<keywords language="eng"><keyword>Antioxidant activity</keyword>
<keyword>scavenging activity</keyword>
<keyword>liver functions</keyword>
<keyword>serum lipid profile</keyword>
<keyword>glutathione fractions</keyword>
<keyword>reactive oxygen species</keyword>
<keyword>malonaldehyde</keyword>
</keywords>
</record>
</records>
